购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-82 (Compound 156) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,在雌二醇的 IC50 测试中展示出 ≤ 0.1 μM 的低值。该化合物主要应用于研究肝病、代谢性疾病或心血管疾病,例如 NAFLD、NASH,以及药物性肝损伤 (DILI)。
HSD17B13-IN-82 (Compound 156) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,在雌二醇的 IC50 测试中展示出 ≤ 0.1 μM 的低值。该化合物主要应用于研究肝病、代谢性疾病或心血管疾病,例如 NAFLD、NASH,以及药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-82 (Compound 156) serves as a potent inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 of ≤ 0.1 μM against estradiol. This compound is useful in studying various liver and metabolic disorders, including NAFLD, NASH, and drug-induced liver injury (DILI), as well as cardiovascular diseases [1]. |
分子量 | 556.75 |
分子式 | C24H15Cl3F3N3O3 |
CAS No. | 2770247-47-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.